Aligos Therapeutics, Inc. · NASDAQ:ALGS

Lawrence M. Blatt, Ph.D. reported a 3.20% stake in Aligos Therapeutics, Inc. (Schedule 13D/A)

Event Mar 10, 2025 · Filed Mar 12, 2025

Lawrence M. Blatt, Ph.D. reported a 3.20% stake in Aligos Therapeutics, Inc., 175,509 shares, with active intent on Mar 10, 2025. Filed Mar 12, 2025 (Schedule 13D/A).

Stake
3.20%
Shares
175,509
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Lawrence M. Blatt, Ph.D.3.20%175,509

Source

View original at SEC

Related